[Korzun]

2013 ACCF/AHA Guideline for the Management of Heart Failure
ИБС = стадия А или В ХСН. Не назначение иАПФ при ХСН = врачебная ошибка.

[Изображения доступны только зарегистрированным пользователям]

AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update

ACE inhibitors
Class I1ACE inhibitors should be started and continued indefinitely in all patients with left ventricular ejection fraction ≤40% and in those with hypertension, diabetes, or chronic kidney disease, unless contraindicated (124,125). (Level of Evidence: A)
Class IIa1It is reasonable to use ACE inhibitors in all other patients (126). (Level of Evidence: B)

2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease

4.4.2.3. RENIN-ANGIOTENSIN-ALDOSTERONE BLOCKER THERAPY
CLASS I
1. ACE inhibitors should be prescribed in all patients with SIHD who
also have hypertension, diabetes mellitus, LVEF 40% or less, or CKD,
unless contraindicated (295–298,301). (Level of Evidence: A)
2. ARBs are recommended for patients with SIHD who have hypertension,
diabetes mellitus, LV systolic dysfunction, or CKD and have
indications for, but are intolerant of, ACE inhibitors (792–794).
(Level of Evidence: A)
CLASS IIa
1. Treatment with an ACE inhibitor is reasonable in patients with both
SIHD and other vascular disease (795,796). (Level of Evidence: B)
2. It is reasonable to use ARBs in other patients who are ACE inhibitor
intolerant (797). (Level of Evidence: C)

И т.д.

Если цель лечения - продлить жизнь, то без иАПФ и БАБ никак.

Руководства по лечению кардиологических болезней можно найти по ссылкам:
[Ссылки доступны только зарегистрированным пользователям ]
[Ссылки доступны только зарегистрированным пользователям ]
[Ссылки доступны только зарегистрированным пользователям ] (это на русском).